Literature DB >> 14502665

Patients', doctors', and caregivers' assessment of disability using the UPDRS-ADL section: are these ratings interchangeable?

Pablo Martínez-Martín1, Julian Benito-León, Fernando Alonso, M José Catalán, Margarita Pondal, Aurelio Tobías, Ivana Zamarbide.   

Abstract

This multicenter study sought to analyze the validity and reliability of the Unified Parkinson's Disease Rating Scale (UPDRS)-section 2 (Activities of Daily Living, ADL) as applied by patients and caregivers. Sixty pairs of PD patients-caregivers were enrolled for study purposes. Neurologists used a set of scales to determine disease severity and patients' functional state. Patients and caregivers used adapted versions of the UPDRS-section 2 in tandem with other measures. Wilcoxon and Mann-Whitney tests, weighted kappa, intraclass and Spearman's correlation coefficients, as well as multivariate linear regression models were applied. On the whole, PD patient self-assessment and caregiver evaluation of patients' disability showed close concordance with neurologists' ratings. Correlation between caregiver ratings and clinical evaluation tended to be slightly lower than that for patient-based self-assessment. Depression showed a positive correlation with disability and had a nonsystematic influence on UPDRS-section 2 (ADL) scores. As expected, there was a significant correlation between perceived disability and health-related quality of life measures. Caregiver burden did not reduce the level of agreement with neurologists as to the overall rating of any given patient's disability. In PD, UPDRS-section 2-based assessment of disability by patients themselves and caregivers is a valid and reliable outcome. Copyright 2003 Movement Disorder Society

Entities:  

Mesh:

Year:  2003        PMID: 14502665     DOI: 10.1002/mds.10479

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  18 in total

1.  Subject-investigator reproducibility of the Unified Parkinson's Disease Rating Scale.

Authors:  Sydney E Seidel; Barbara C Tilley; Peng Huang; Yuko Y Palesch; Kenneth J Bergmann; Christopher G Goetz; Christopher J Swearingen
Journal:  Parkinsonism Relat Disord       Date:  2011-10-21       Impact factor: 4.891

2.  Assessing self-awareness of dyskinesias in Parkinson's disease through movie materials.

Authors:  Emilia J Sitek; Witold Soltan; Darius Wieczorek; Piotr Robowski; Michal Schinwelski; Jaroslaw Slawek
Journal:  Funct Neurol       Date:  2011 Jul-Sep

3.  Delayed Parkinson's disease diagnosis among African-Americans: the role of reporting of disability.

Authors:  Nabila Dahodwala; Jason Karlawish; Andrew Siderowf; John E Duda; David S Mandell
Journal:  Neuroepidemiology       Date:  2011-04-20       Impact factor: 3.282

4.  Functional improvement after subthalamic stimulation in Parkinson's disease: a non-equivalent controlled study with 12-24 month follow up.

Authors:  M Capecci; R A Ricciuti; D Burini; V G Bombace; L Provinciali; M Iacoangeli; M Scerrati; M G Ceravolo
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-06       Impact factor: 10.154

5.  Measurement of patient-centered outcomes in Parkinson's disease: what do patients really want from their treatment?

Authors:  Anne N Nisenzon; Michael E Robinson; Dawn Bowers; Evangelia Banou; Irene Malaty; Michael S Okun
Journal:  Parkinsonism Relat Disord       Date:  2010-10-16       Impact factor: 4.891

6.  Outcome measures for Parkinson's disease dementia: a systematic review.

Authors:  Samantha K Holden; Wallace E Jones; Keith A Baker; Isabel M Boersma; Benzi M Kluger
Journal:  Mov Disord Clin Pract       Date:  2015-09-16

7.  Differences of self-reported osteoarthritis disability and race.

Authors:  Robert Burns; Marshall J Graney; Allan C Lummus; Linda O Nichols; Jennifer Martindale-Adams
Journal:  J Natl Med Assoc       Date:  2007-09       Impact factor: 1.798

8.  Cognitive and motor deficits in older adults with HIV infection: Comparison with normal ageing and Parkinson's disease.

Authors:  Eva M Müller-Oehring; Rosemary Fama; Taylor F Levine; Cheshire Hardcastle; Ryan Goodcase; Talora Martin; Varsha Prabhakar; Helen M Brontë-Stewart; Kathleen L Poston; Edith V Sullivan; Tilman Schulte
Journal:  J Neuropsychol       Date:  2020-10-08       Impact factor: 2.864

9.  Psychometric properties of the Berg balance scale in idiopathic Parkinson' disease in the drug off-phase.

Authors:  Ghorban Taghizadeh; Pablo Martinez-Martin; Seyed-Mohammad Fereshtehnejad; Seyed Amirhasan Habibi; Negar Nikbakht; Naeeme Haji Alizadeh; Sheyda Salehi; Maryam Mehdizadeh
Journal:  Neurol Sci       Date:  2018-09-22       Impact factor: 3.307

10.  Problem solving therapy for the treatment of depression for a patient with Parkinson's disease and mild cognitive impairment: a case study.

Authors:  R Scott Mackin; Patricia Areán; Alexandra Elite-Marcandonatou
Journal:  Neuropsychiatr Dis Treat       Date:  2006-09       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.